xpeer logo
© Xpeer 2026 All rights reserved
Privacy Policy - Terms of Use - Help

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account
Course Preview

Genomic Testing in Oncology

Free
1h 1min
Audio: English

Synopsis

Cancer care is rapidly evolving, driven by increasing biological complexity and the need for more precise, timely, and personalized approaches to diagnosis and treatment. In this course, leading experts explore the future of oncology applications, focusing on how emerging technologies such as liquid biopsy, comprehensive genomic profiling (CGP), and whole genome and transcriptome sequencing (WGTS) are transforming clinical practice. Through a series of video modules, participants will gain insight into how these approaches improve diagnostic accuracy, guide therapy selection, enable detection of resistance and disease monitoring, and support earlier and less invasive testing strategies. The course also highlights the added value of combining different omics to unlock deeper understanding of tumor biology, alongside practical considerations for clinical implementation, including workflow integration, turnaround time, and data interpretation. This activity is supported by an independent support grant from Illumina.

Objectives

  • Describe the role of genomic technologies (CGP, liquid biopsy, WGTS) in cancer care
  • Explain how these approaches improve diagnosis, patient stratification, and therapy selection
  • Evaluate the clinical utility of advanced genomic testing across different stages of the patient pathway
  • Recognize the impact of emerging technologies (e.g., liquid biopsy, multi-omics) on understanding tumor biology
  • Apply key considerations for integrating genomic testing into routine clinical practice

Duration

1h 1min

Target audience

Medical genetics

Authors

Prof. Isabelle Ray-Coquard

Prof. Isabelle Ray-Coquard is a prominent oncologist based at the Centre Léon Bérard in Lyon, France, where she specializes in rare gynaecological cancers and sarcomas. She obtained her medical degree in 1997 and has since developed a significant focus on translational research, particularly in ovarian cancer, coordinating the national reference center for rare ovarian cancers. Prof. Ray-Coquard has held various leadership roles in cancer research organizations, including serving as the clinical chair of the ENGOT network and Past President of the GINECO group, which is dedicated to gynaecological cancer research. She is also involved in multidisciplinary consultation meetings for sarcomas and gastrointestinal stromal tumors (GISTs). Her contributions to the field are recognized through her extensive publications and active participation in international oncology societies, emphasizing her commitment to improving treatment outcomes for patients with rare cancers.

Testimonials

“Xpeer is a magnificent platform for healthcare professionals, where you can gain knowledge from a scientific and highly up-to-date perspective across various medical specialties.”

Wil A. onTrustpilot

Netherlands

“I've taken several courses on Xpeer and they've been very useful. The format is very dynamic, allowing you to watch the videos in your free time since they're no longer than 15 minutes. The topics are very current.”

Francisco P. onTrustpilot

Spain

“Excellent platform to stay up to date and keep learning throughout your professional career. I recommend it to all my colleagues.”

Omar I. onTrustpilot

Spain

Read more reviews onTrustpilot

FAQs

What you will learn

Tissue CGP

  • Benefits of Next Generation Sequencing (NGS) biomarker testing for cancer patients
  • Comprehensive genomic profiling utility in lung cancer
  • Does finding a rare mutation accomplish anything?
  • Testing for NTRK fusions
  • How can in-couse CGP HRD benefit pancreatic cancer patients?
  • HRD testing in ovarian cancer

Liquid CGP

  • How is liquid biopsy reshaping lung cancer tumour profiling in cancer care?
  • Liquid biopsy NGS in cancer care
  • Clinical utility of ctDNA testing in lung cancer - biomarker testing and MRD
  • ctDNA - guided treatment in colorectal cancer

WGTS and WES

  • Advantages of comprehensive cancer whole exome sequencing
  • Whole-genome sequencing (WGS) improves diagnosis of sarcomas
  • Whole-genome sequencing (WGS) in acute myeloid leukemia (AML)

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account